UC San Diego Distinguished Professor of Chemistry Mark Thiemens is the 43rd recipient of the Magellanic Premium, given by the American Philosophical Society. Thiemens was recognized for his groundbreaking work in mass-independent isotope fractionation.
A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.
Susumu Tonegawa, who made key contributions to immunology and neurobiology and became UC San Diego’s first alumnus to receive a Nobel Prize, passed away on July 11. His research resolved a long-standing puzzle about how the immune system generates millions of antibodies from a small set of genes.
Does experiencing art have the capacity to quiet an overactive mind and inspire a state of awe? An audio artist, neuroscientist and visual designer at UC San Diego have teamed up to find out. Their unique project received $50K in private support from the Bobby Anspach Studios Foundation.
Cross country and track and field scholar-athlete Thomas Fry measures success by the conversations that happen away from competition: the ones that help athletes feel supported, understood, and empowered as a mental health advocate.